chartexchange

Star adds $200M after spinout successes

BioPharma Dive | Oct 23, 2026 7:00 AM EDT

Following exits for its subsidiaries Electra Therapeutics and Vega Therapeutics, Star is now mining for a new drug prospect.

Read original article